Goldman Sachs Future Health Care Equity ETF (GDOC)
Holdings data is not available for this fund yet.
GDOC Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Performance as of Oct. 2, 2026
| Period | Price return | Total return |
|---|---|---|
| 1M | ▼ -3.14% | ▼ -3.14% |
| 3M | · | · |
| 6M | · | · |
| YTD | · | · |
| 1Y | · | · |
| 3Y | · | · |
| 5Y | · | · |
| Max | ▼ -2.95% | ▼ -2.95% |
Total return assumes dividends are reinvested. Returns are not benchmarked against an index. * Sharpe ratio is computed with a 0% risk-free rate.
Fund flows (SEC-reported)
Based on the fund's own SEC Form N-PORT monthly flow disclosures (Item C.9 "Flow Information") — sales minus redemptions, reinvested distributions excluded. This is a different, independent metric from the "Net flows" estimate above (which is derived from daily shares-outstanding changes). SEC N-PORT filing lag is up to ~60 days; the most recent month/quarter may not yet be fully reflected.
Full composition 42 holdings
| Name | CUSIP | Value | % | Balance | Category | Country |
|---|---|---|---|---|---|---|
| ELI LILLY & COMPANY | 532457108 | $2.7M | 13.28 | 2,417 | EC | US |
| JOHNSON & JOHNSON | 478160104 | $1.6M | 8.07 | 7,204 | EC | US |
| MERCK & COMPANY INC | 58933Y105 | $1.2M | 5.94 | 10,073 | EC | US |
| GUARDANT HEALTH INC | 40131M109 | $1.1M | 5.34 | 8,286 | EC | US |
| ASTRAZENECA PLC | · | $974K | 4.84 | 5,234 | EC | GB |
| THERMO FISHER SCIENTIFIC INC | 883556102 | $910K | 4.52 | 1,847 | EC | US |
| ARGENX SE | 04016X101 | $818K | 4.07 | 979 | EC | NL |
| INTUITIVE SURGICAL INC | 46120E602 | $785K | 3.90 | 1,849 | EC | US |
| BOSTON SCIENTIFIC CORP | 101137107 | $760K | 3.78 | 15,740 | EC | US |
| HOYA CORP | · | $710K | 3.53 | 4,173 | EC | JP |
| EDWARDS LIFESCIENCES CORP | 28176E108 | $600K | 2.98 | 6,939 | EC | US |
| LONZA GROUP AG | · | $563K | 2.80 | 879 | EC | CH |
| DEXCOM INC | 252131107 | $562K | 2.79 | 7,621 | EC | US |
| AGILENT TECHNOLOGIES INC | 00846U101 | $556K | 2.77 | 4,105 | EC | US |
| ROIVANT SCIENCES LTD | · | $481K | 2.39 | 16,036 | EC | BM |
| CENCORA INC | 03073E105 | $471K | 2.34 | 1,750 | EC | US |
| APOGEE THERAPEUTICS INC | 03770N101 | $396K | 1.97 | 4,823 | EC | US |
| ROYALTY PHARMA PLC | · | $355K | 1.77 | 6,370 | EC | GB |
| PENUMBRA INC | 70975L107 | $323K | 1.61 | 1,015 | EC | US |
| METTLER-TOLEDO INTERNATIONAL INC | 592688105 | $320K | 1.59 | 271 | EC | US |
| VERTEX PHARMACEUTICALS INC | 92532F100 | $299K | 1.48 | 667 | EC | US |
| GOLDMAN SACHS TRUST | 38141W323 | $288K | 1.43 | 287,989 | STIV | US |
| CYTOKINETICS INC | 23282W605 | $281K | 1.40 | 3,663 | EC | US |
| IONIS PHARMACEUTICALS INC | 462222100 | $276K | 1.37 | 3,614 | EC | US |
| XENON PHARMACEUTICALS INC | 98420N105 | $272K | 1.35 | 4,977 | EC | CA |
| UNITEDHEALTH GROUP INC | 91324P102 | $272K | 1.35 | 715 | EC | US |
| REPLIGEN CORP | 759916109 | $253K | 1.26 | 2,038 | EC | US |
| INSMED INC | 457669307 | $222K | 1.11 | 2,081 | EC | US |
| GALDERMA GROUP AG | · | $220K | 1.10 | 1,034 | EC | CH |
| MADRIGAL PHARMACEUTICALS INC | 558868105 | $214K | 1.06 | 430 | EC | US |
| REVOLUTION MEDICINES INC | 76155X100 | $168K | 0.84 | 1,069 | EC | US |
| CG ONCOLOGY INC | 156944100 | $151K | 0.75 | 2,432 | EC | US |
| BRIDGEBIO PHARMA INC | 10806X102 | $147K | 0.73 | 2,214 | EC | US |
| QUEST DIAGNOSTICS INC | 74834L100 | $144K | 0.72 | 741 | EC | US |
| RHYTHM PHARMACEUTICALS INC | 76243J105 | $136K | 0.68 | 1,538 | EC | US |
| ALKERMES PLC | · | $114K | 0.57 | 2,703 | EC | IE |
| SARTORIUS STEDIM BIOTECH SA | · | $111K | 0.55 | 533 | EC | FR |
| PRAXIS PRECISION MEDICINES INC | 74006W207 | $111K | 0.55 | 316 | EC | US |
| DEFINIUM THERAPEUTICS INC | 24477V105 | $102K | 0.51 | 4,214 | EC | CA |
| SPYRE THERAPEUTICS INC | 00773J202 | $71K | 0.35 | 960 | EC | US |
| INSULET CORP | 45784P101 | $58K | 0.29 | 398 | EC | US |
| STRUCTURE THERAPEUTICS INC | 86366E106 | $40K | 0.20 | 1,008 | EC | KY |
Dividends 3 payments
| Ex-date | Amount / share |
|---|---|
| Dec. 23, 2025 | $0.1130 |
| Dec. 23, 2024 | $0.0060 |
| Dec. 26, 2023 | $0.1790 |
Institutional owners (13F) 8 filers
Institutions that report holding this ETF in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
| Institution | Value | % of tracked 13F | Shares | Type | As of |
|---|---|---|---|---|---|
| GOLDMAN SACHS GROUP INC | $9,422,569 | 81.90% | 261,325 | Shares | June 30, 2026 |
| MORGAN STANLEY | $944,655 | 8.21% | 26,199 | Shares | June 30, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $459,401 | 3.99% | 12,741 | Shares | June 30, 2026 |
| J. Mark Nickell & Co. | $232,964 | 2.02% | 7,143 | Shares | March 31, 2026 |
| CWM, LLC | $228,235 | 1.98% | 6,998 | Shares | March 31, 2026 |
| CITADEL ADVISORS LLC | $216,161 | 1.88% | 5,995 | Shares | June 30, 2026 |
| UBS Group AG | $1,082 | 0.01% | 30 | Shares | June 30, 2026 |
| FLOW TRADERS U.S. LLC | $414 | 0.00% | 11,481 | Shares | June 30, 2026 |